Atlas Trials

Study of Romiplostim(AMG531) in Subjects With Aplastic Anemia

Clinical trial NCT02773290 · COMPLETED

Trial details

NCT number
NCT02773290
Sponsor
Kyowa Kirin Co., Ltd.
Status
COMPLETED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Aplastic Anemia
Start date
2016-05-01
Primary completion
2017-11-14
Enrollment
46

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.